Caenorhabditis elegans Show Preference for Stimulants and Potential as a Model Organism for Medications Screening

Frontiers in Physiology
Eric A EnglemanBethany S Neal-Beliveau

Abstract

The nematode Caenorhabditis elegans (C. elegans) is a popular invertebrate model organism to study neurobiological disease states. This is due in part to the intricate mapping of all neurons and synapses of the entire animal, the wide availability of mutant strains, and the genetic and molecular tools that can be used to manipulate the genome and gene expression. We have shown that, C. elegans develops a conditioned preference for cues that had previously been paired with either cocaine or methamphetamine exposure that is dependent on dopamine neurotransmission, similar to findings using place conditioning with rats and mice. In the current study, we show C. elegans also display a preference for, and self-exposure to, cocaine and nicotine. This substance of abuse (SOA) preference response can be selectively blocked by pretreatment with naltrexone and is consistent with the recent discovery of an opioid receptor system in C. elegans. In addition, pre-exposure to the smoking cessation treatment varenicline also inhibits self-exposure to nicotine. Exposure to concentrations of treatments that inhibit SOA preference/self-exposure did not induce any significant inhibition of locomotor activity or affect food or benzaldehyde chemotax...Continue Reading

References

May 1, 1992·Trends in Pharmacological Sciences·G F Koob
Jan 1, 1991·Psychopharmacology·W A Corrigall, K M Coen
Dec 16, 1998·Science·C I Bargmann
Sep 4, 2004·Genes, Brain, and Behavior·J C Bettinger, S L McIntire
Mar 21, 2006·Pharmacology & Therapeutics·Markus Heilig, Mark Egli
Dec 1, 2007·WormBook : the Online Review of C. Elegans Biology·Cornelia I Bargmann
Jun 19, 2009·PloS One·Alex WardX Z Shawn Xu
Jul 21, 2009·Genes, Brain, and Behavior·J LeeS L McIntire
Aug 28, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·George F Koob, Nora D Volkow
Oct 23, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Xiu Liu, Courtney Jernigan
Apr 19, 2011·Nature Neuroscience·Karla R KaunUlrike Heberlein
Jun 1, 2011·Pharmacology, Biochemistry, and Behavior·Robert SobkowiakAndrzej Lesicki
Jan 11, 2012·Methods in Molecular Biology·Scott Edwards, George F Koob
Apr 11, 2012·Alcoholism, Clinical and Experimental Research·Joseph T AlaimoJill C Bettinger
May 31, 2012·Behavioral Neuroscience·Heather N MusselmanEric A Engleman
Nov 6, 2012·Cold Spring Harbor Perspectives in Medicine·S Stevens Negus, Matthew L Banks
Jan 10, 2013·Psychopharmacology·Chiara GiulianoBarry J Everitt
Jan 29, 2013·The European Journal of Neuroscience·Laurie SellingsDerek van der Kooy
Feb 4, 2014·Advances in Pharmacology·Peter A CrooksLinda P Dwoskin
Apr 1, 2014·PloS One·Stephen M TopperJonathan T Pierce-Shimomura
Jul 18, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Scott J DavisJonathan T Pierce-Shimomura
Sep 25, 2014·Frontiers in Physiology·Jill C Bettinger, Andrew G Davies
Nov 28, 2014·Bioscience, Biotechnology, and Biochemistry·Tetsuya Matsuura, Takuya Urushihata
Apr 17, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Margaret HaneyZiva D Cooper
Apr 22, 2015·ELife·Mi Cheong CheongLeon Avery
Jul 16, 2015·Alcoholism, Clinical and Experimental Research·Mike Grotewiel, Jill C Bettinger
Jan 27, 2016·Progress in Molecular Biology and Translational Science·Eric A EnglemanBethany S Neal-Beliveau
May 20, 2016·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Holly MillsRichard Komuniecki
Jun 9, 2016·Expert Opinion on Pharmacotherapy·Jose L BarbozaKaren Suchanek Hudmon
Jul 13, 2016·CNS Drugs·Elias Aboujaoude, Wael O Salame
Oct 26, 2016·Pharmacology, Biochemistry, and Behavior·Ari P KirshenbaumMaiary Voltolini de Souza Pinto
Dec 19, 2017·Pharmacotherapy·Nieves Gómez-CoronadoSeetal Dodd

❮ Previous
Next ❯

Citations

Nov 3, 2020·Frontiers in Behavioral Neuroscience·Greer McKendrick, Nicholas M Graziane
Apr 30, 2021·G3 : Genes - Genomes - Genetics·Soren EmersonRachid El Bejjani

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Software Mentioned

ImageJ
Excel

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Basal Forebrain & Food Avoidance

Neurons in the basal forebrain play specific roles in regulating feeding. Here are the latest discoveries pertaining to the basal forebrain and food avoidance.